Image
Practice Point
Bone-modifying agents – Dental care
Refer all patients to a dentist for preventative and ongoing dental care before commencing treatment with a bone-modifying agent.
A dental assessment is recommended, where feasible, prior to commencement of bisphosphonates, and any pending dental or oral health problems should be dealt with prior to starting treatment, if possible. Patients should be informed of the risk of developing ONJ, especially with tooth extractions and other invasive dental procedures. Patients should inform their dental practitioner of their treatment. Patients with suspected ONJ should be referred to a dental practitioner with expertise in treating this condition
How this guidance was developed
No evidence-based source recommendation was identified for this topic, which was considered an important aspect of care. This practice point was developed using an expert consensus process.
This practice point is informed by a recommendation (not graded, based on a systematic review of the evidence) in the CCO/ASCO 2017 clinical practice guideline on the use of adjuvant bisphosphonates and other bone-modifying agents in breast cancer.
Bone-modifying agents – Dental care
Practice Point
Refer all patients to a dentist for preventative and ongoing dental care before commencing treatment with a bone-modifying agent.
Principles in action
Supportive care
Image
Communication
No evidence-based source recommendation was identified for this topic, which was considered an important aspect of care. This practice point was developed using an expert consensus process.
This practice point is informed by a recommendation (not graded, based on a systematic review of the evidence) in the CCO/ASCO 2017 clinical practice guideline on the use of adjuvant bisphosphonates and other bone-modifying agents in breast cancer.